CWRU researchers uncover biochemical rules between RNA-protein interactions and expr

February 10, 2021

CLEVELAND--A team of Case Western Reserve University researchers has found a way to measure key characteristics of proteins that bind to RNA in cells--a discovery that could improve our understanding of how gene function is disturbed in cancer, neurodegenerative disorders or infections.

RNA--short for ribonucleic acid--carries genetic instructions within the body. RNA-binding proteins play an important role in the regulation of gene expression. Scientists already knew that the way these proteins function depends on their "binding kinetics," a term that describes how frequently they latch on to a site in an RNA, and how long they stay there.

Until now, researchers could not measure the kinetics of RNA-binding proteins in cells. But the Case Western Reserve researchers answered this longstanding question in RNA biology. The findings open the door to a biochemical understanding of RNA protein interactions in cells.

By understanding the kinetics, researchers can quantitatively predict how an RNA binding protein regulates the expression of thousands of genes, which is critical for developing strategies that target RNA protein interactions for therapeutic purposes.

"The study marks a major step toward understanding how gene function is regulated and how to devise ways to correct errors in this regulation in diseases such as cancer, neurodegenerative disorders or infections," said Eckhard Jankowsky, the study's principal author and a professor of biochemistry at the university's School of Medicine and director of the school's Center for RNA Science and Therapeutics .

Their study, "The kinetic landscape of an RNA binding protein in cells," was published Feb. 10 in Nature. Funding from the National Institute of General Medical Sciences and the National Science Foundation supported the research.

The co-authors, all from Case Western Reserve, are: research associate Deepak Sharma; graduate students Leah Zagore, Matthew Brister and Xuan Ye; Carlos Crespo-Hernández, a chemistry professor; and Donny Licatalosi, an associate professor of biochemistry and member of the Center for RNA Science and Therapeutics.

To measure the kinetics of RNA binding proteins, the researchers used a laser that sends out extremely short (femtosecond) pulses of ultraviolet light to cross-link the RNA-binding protein known as DAZL to its several thousand binding sites in RNAs. (DAZL, short for Deleted in Azoospermia-Like, is involved in germ cell development.) They then used high throughput sequencing to measure the change of the crosslinked RNA over time and determined the binding kinetics of DAZL at thousands of binding sites.

The resulting "kinetic landscape" allowed the researchers to decode the link between DAZL binding and its effects on RNAs.
Case Western Reserve University is one of the country's leading private research institutions. Located in Cleveland, we offer a unique combination of forward-thinking educational opportunities in an inspiring cultural setting. Our leading-edge faculty engage in teaching and research in a collaborative, hands-on environment. Our nationally recognized programs include arts and sciences, dental medicine, engineering, law, management, medicine, nursing and social work. About 5,100 undergraduate and 6,700 graduate students comprise our student body. Visit to see how Case Western Reserve thinks beyond the possible.

Case Western Reserve University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to